Nephrology Flashcards
definition of AKI
increase in sCr > 0.3 or 1.5x baseline in last week
anuria definition
urine output <50ml/day
functional kidney injury causes
low blood flow
does not allow the kidneys to fxn as well
concentrated urine
intrinsic kidney injury
infections or physical injury
urine is NOT concentrated
drugs that hurt the kidneys
bactrim - inhibit tubular secretion of cr
cimetidine - inhibit tubular secretion of cr
corticosteroids - increase BUN
Tetracyclines - increase BUN
cephalosporins - interfere with cr assay
aminoglycosides - tubular necrosis
contrast dye - tubular necrosis
cisplatin - tubular necrosis
amphotericin B - tubular necrosis
risk factors for nephrotoxicity with contrast dye
> 75 yo, anemia, DM, hypovolemia, decreased blood flow to kidney, hypotension, nephrotoxins, >140ml of contrast, kidney disease
ACE/ARB effects on kidneys
dilates the efferent arteriole
NSAID effects on kidneys
constrict afferent arteriole and reduce glomerular blood flow,
cyclosporine and tacrolimus effect on kidneys
constrict afferent arterioles
drugs that may cause tubulostitial disease
PCN
NSAIDs
Lithium
drugs that cause postrenal (obstructive) nephropathy
sulfonamides, methotrexate, acyclovir, vitamin C
drugs that cause nephrolithiasis
triamterene, sulfadiazine, ephedrine
diabetic kidney disease
ACEi/ARB
Patiromer to bind K
HCTZ if stage 1-3, loop diuretic if stage 4-5
SGLT2 if DM, GFR>30, and ACR > 300
thrombosis tx w/hemodialysis
alteplase 2mg OR
reteplase 0.4 units
antibiotics to use for infected peritoneal cavity
vanc or 1st gen cephalosporin
PLUS
3rd gen cephalosporin, aminoglycoside, or aztreonam
what medical condition contraindicates ESA’s?
uncontrolled hypertension
Procrit dose (epoetin-alfa)
Epogen
SC or IV
50-100units/kg TIW
Darbepoetin alfa (Aranesp)
SC or IV
Non-Dialysis: 0.45mcg/kg q4w
Dialysis: 0.45mcg/kg qweekly or 0.75mcg/kg q2w
Mircera (methoxy-polyethylene glycol-epoetin beta)
takes 7-15 days after initial dose to see effects
SC or IV
0.6 mcg/kg q2w
when to use iron supplements
serum ferritin <500ng/mL
OR
serum transferrin sat <30%
iron dextran dosing
25mg test dose then
1g at once
OR
100mg IV TIW x 10 doses
sodium ferric gluconate complex
Ferrlecit
125mg IV TIW x 8 doses
Iron Sucrose
100mg IV TIW x 10 doses in Hemodialysis
200mg IV daily x 5 doses in Non-HD patients
Ferumoxytol
Feraheme
510mg x 2, 3-8 days apart
Ferric Carboxymaltose
Injectafer
750mg x 2, 7 days apart
what happens to phosphorous and calcium when CrCl <30ml/min
parathyroid hormone leeches calcium from the bones, decreases reabsorption of calcium from kidneys
calcium supplements for CKD
calcium carbonate 1250mg TID
calcium acetate (Phoslo) 667mg tabs
may decrease metabolic acidosis
Sevelamer dosing
Renvela and Fosrenol
decreases LDL and increases HDL
may worsen metabolic acidosis
may increase hypercalcemia
Vit D Dosing
<5: weekly x 12, then monthly
5 - 15: weekly x 4, then monthly
16 - 30: monthly dosing
Cacitriol
active Vitamin D3
PO or IV
0.25mcg daily for hypocalcemia and 2ndary hyperparathyroidism
MOA: increases calcium and phosphate absorption from the small intestine, increases bone mineralization indirectly by increasing ions from absorption, may also cause bone absorption in bone remodeling, in kidneys it causes more reabsorption of Ca and Phos
Vitamin D 2 brand name
ergocalciferol
inactive
Vitamin D 3 brand name
cholecalciferol
inactive
vitamin d - calcium - phosphorous pathways
liver converts D3 to another form w/magnesium, then kidney converts to active vitamin d w/magnesium
D is made active if we need calcium absorption, if not it is made into an inactive form and excreted
this conversion is regulated by calcium, phosphate, and PTH
calcium mimetics on the market for hyperparathyroidism
calcitriol - active vitamin D
paricalcitol - D analog, IV
Doxercalciferol - D analog IV, requires hepatic activation
analogs less hyper-Ca than calcitriol
Cinacalcet (Sensipar) for secondary hyperparathyroidism
use for secondary high PTH if high calcium and phos and d cannot be increased
will attach to PTH gland and increase sensitivity to serum Ca to reduce PTH, decreases blood Ca via increased uptake
30mg daily
cinacalcet drug interactions
2D6 inhibitor - increases TCA’s, flecainide, and thioridazine
3A - doubles [x] of ketoconazole
etelcalcetide (parsabiv)
synthetic cinacalcet, same MOA
5mg IV TIW after HD
stays in blood for a month